Skip to main content
. 2005 Jul 15;4:6. doi: 10.1186/1475-2883-4-6

Table.

Ivermectin treatment coverage of the eligible population (1995–1999) and LF antigenemia (1999) among male residents in five ivermectin treated villages, with 1999 LF antigenemia in one untreated village (Gwamlar)

Village Angwan Lemu Apanda Bakin-Kogi Lankan Mungkohot Gwamlar
Ivermectin rounds 2 2 2 5 5 -
Mean coverage (range) 91.4% (91–92) 66.9% (58–76) 85.3% (82–89) 85.9% (65–95) 77% (73–80) -
1999 coverage 92% 58% 89% 90% 80% -
% LF antigenemia in males (n) 40% (30) 43% (30) 27% (30) 47% (30) 47% (30) 58% (50)
HHS Vulnerability Disclosure